A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
Clinical trial NCT06628687 · RECRUITING
Trial details
- NCT number
- NCT06628687
- Sponsor
- Biogen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-10-26
- Primary completion
- 2035-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.